P-BCMA-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Multiple Myeloma
Clinical trial NCT04960579 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04960579
- Sponsor
- Poseida Therapeutics, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-05
- Primary completion
- 2029-03-01
- Enrollment
- 275
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.